The leaders of the healthcare organization are expected to select am organization-wide performance improvement approach and to clearly define how all levels of the organization will monitor and address improvement issues. The Joint Commission requires ongoing data collection that might require improvement for which of the following areas?
A. Operative and other invasive procedures, medication management, and blood and blood
product use
B. Blood and blood product use, medication management, and appointment to the board of
directors
C. Medication management, marketing strategy, and blood use
D. Operative and other invasive procedures, appointments to the board of directors, and restraint and seclusion use